^

Affiliate

Rachel Jimenez

ADROP President

Harvard Radiation Oncology Program

Education

  • MD, Harvard Medical School, Boston, 2009
  • AB: Cognitive Neuroscience, Harvard College, Cambridge, Massachusetts, 2000

Postgraduate Education

  • Preliminary Year, Beth Israel Deaconess Medical Center, Boston, 2010
  • Residency: Radiation Oncology, Harvard Radiation Oncology Program, Boston 2014

Academic Appointments

  • Associate Program Director, Harvard Radiation Oncology Program, present
  • Assistant Professor of Radiation Oncology, Harvard Medical School, present

Hospital/Institution Appointments:

  • Massachusetts General Hospital, Boston, 2014-present

Dr. Jimenez is an Assistant Professor of Radiation Oncology at Harvard Medical School, the Associate Program Director for the Harvard Radiation Oncology Program, and an attending radiation oncologist at Massachusetts General Hospital, Boston, MA. Dr. Jimenez has a longstanding interest in the education of radiation oncology trainees. She is a Steering Committee member for the Radiation Oncology Education Collaborative Study Group (ROECSG) and has co-led the development of an Introductory Radiation Oncology Curriculum (IROC), a program for educating incoming PGY-2 radiation oncology residents that is currently utilized at the majority of US radiation oncology training programs. Dr. Jimenez is also involved with the ROVER 2.0 initiative, providing virtual case-based radiation oncology education for residents across the US and she serves as the faculty mentor for the Radiation Oncology Intensive Shadowing Experience (RISE), a Harvard-based virtual shadowing program designed to provide 4th year medical students who are underrepresented in medicine (UIM) greater exposure to the field of radiation oncology. Dr. Jimenez serves on the Annual Meeting Education Committee for the American Society for Radiation Oncology (ASTRO), the Faculty Advisory Council for ARRO’s Equity and Inclusion Subcommittee, and is an American Board of Radiology (ABR) volunteer in Breast Cancer.